B.R.A.I.N. Biotechnology Research And Information Network AG (ETR:DE000520)

BRIEF

published on 02/26/2025 at 07:35, 1 year 8 months ago

BRAIN Biotech AG Reports Double-Digit Growth in Q1 2024/25

Adjusted EBITDA Revenue Increase BRAIN Biotech AG BRAINBiocatalysts Q1 Growth 2024/25
PRESS RELEASE

published on 02/26/2025 at 07:30, 1 year 8 months ago

BRAIN Biotech AG: 3M FY 24/25 - Starting the year with double digit sales growth in the core BRAINBiocatalysts division
BRAIN Biotech AG reports 11% organic growth in Q1 of FY 24/25 for BRAINBiocatalysts, forecasts strong growth and solid EBITDA margin, maintains strong cash position of €17.8 million

Financial Results EBITDA Margin Organic Growth BRAIN Biotech AG BRAINBiocatalysts
BRIEF

published on 02/13/2025 at 09:19, 1 year 8 months ago

BRAIN Biotech Partners with PX Group for Biological Gold Recycling

Collaboration Biological Recycling BioXtractor V2 PX Urban Mining Sustainable Gold
PRESS RELEASE

published on 02/13/2025 at 09:14, 1 year 8 months ago

Biological gold recycling: BRAIN Biotech AG collaborates with PX Group on the PX Urban Mining Initiative
BRAIN Biotech AG collaborates with PX Group on the PX Urban Mining Initiative for biological gold recycling, producing BioGold nuggets from local waste. Focus on sustainability

Sustainability BRAIN Biotech AG PX Group Urban Mining Initiative Gold Recycling
BRIEF

published on 01/15/2025 at 07:35, 1 year 9 months ago

BRAIN Biotech AG Maintains Strong Cash Position Amidst Challenging FY 2023/24

Financial Results Cash Position Strategic Transactions Growth Prospects Revenue Stability
PRESS RELEASE

published on 01/15/2025 at 07:30, 1 year 9 months ago

Annual Report 2023/24: BRAIN Biotech AG acts from a strong cash position and is confident about its growth prospects
BRAIN Biotech AG reports strong cash position & growth prospects in Annual Report 2023/24. Closed milestone transactions with Royalty Pharma & Akribion Therapeutics

Cash Position Annual Report Growth Prospects BRAIN Biotech AG Milestone Transactions
BRIEF

published on 12/12/2024 at 09:05, 1 year 10 months ago

BRAIN Biotech AG Refocuses on Profitable Growth

Profitable Growth Financial Forecast Strategic Initiatives BRAIN Biotech Enzyme Business
PRESS RELEASE

published on 12/12/2024 at 09:00, 1 year 10 months ago

BRAIN Biotech AG Sharpens Focus on Profitable Growth
BRAIN Biotech AG sharpens focus on profitable growth by creating new growth segment BRAINBiocatalysts. Targets include EUR 100 million revenues, 15% adjusted EBITDA margin, and high R&D ratio

Profitable Growth Financial Forecast BRAIN Biotech AG Enzyme Business BRAINBiocatalysts
BRIEF

published on 10/31/2024 at 19:25, 2 years ago

Exclusive Licensing Agreement Boosts BRAIN Biotech's Pharma Ventures

BRAIN Biotech CRISPR-Cas Technology G-dase E® Pharma Licensing Akribion Therapeutics
PRESS RELEASE

published on 10/31/2024 at 19:20, 2 years ago

BRAIN Biotech AG and Akribion Therapeutics GmbH sign exclusive pharma licensing agreement for G-dase E® CRISPR-Cas technology
BRAIN Biotech AG signs exclusive pharma licensing agreement with Akribion Therapeutics GmbH for G-dase E(R) CRISPR-Cas technology, offering up to EUR 92.3 million R&D and commercial milestone fees along with royalties

BRAIN Biotech AG CRISPR-Cas Technology Pharma Licensing Agreement Akribion Therapeutics GmbH G-dase E(R)

Published on 11/06/2026 at 13:00, 8 hours 27 minutes ago

Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 8 hours 57 minutes ago

Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 8 hours 57 minutes ago

Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Published on 11/06/2026 at 10:00, 11 hours 27 minutes ago

Mongolia Tax Audit
Published on 11/06/2026 at 05:15, 16 hours 12 minutes ago

Valeo and QNX Unveil A New Smart Camera Platform at CIIE, Secures Multiple Design Wins

View all ACCESSWIRE

Published on 11/06/2026 at 20:15, 1 hour 12 minutes ago

African Medicines Agency Marks First Year of Operations with New Platforms to Strengthen Regulation and Support Manufacturing
Published on 11/06/2026 at 19:15, 2 hours 12 minutes ago

EQS-Adhoc: ABO Energy GmbH & Co. KGaA suspends the interest payment on the bond 2024/2029 due on 8 November 2026.
Published on 11/06/2026 at 19:00, 2 hours 27 minutes ago

Finexity AG: FINEXITY issues 2026/2030 bond with a minimum of 7.00% p.a. – either conventionally in a securities account or as a crypto security in a wallet
Published on 11/06/2026 at 18:32, 2 hours 55 minutes ago

EQS-Adhoc: Finexity AG: FINEXITY issues 2026/2030 bond
Published on 11/06/2026 at 18:00, 3 hours 27 minutes ago

ARVERNE GROUP: Number shares and voting rights

View all EQS

Published on 11/06/2026 at 18:00, 3 hours 27 minutes ago

ICADE - PR - S&P credit rating
Published on 11/06/2026 at 18:00, 3 hours 27 minutes ago

DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
Published on 11/06/2026 at 17:54, 3 hours 33 minutes ago

Disclosure of Share Capital and Voting Rights as of October 31, 2026
Published on 11/06/2026 at 17:35, 3 hours 52 minutes ago

Disclosure of the number of shares and the total number of voting rights as of October 31, 2026
Published on 11/06/2026 at 11:05, 10 hours 22 minutes ago

voting rights

View all LES ECHOS COMFI WIRE

News